Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005! We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare Professionals globally, by translating published data into easily digestible and timely updates Home of: - touchONCOLOGY - touchENDOCRINOLOGY - touchOPHTHALMOLOGY - touchNEUROLOGY - touchCARDIOLOGY - touchINFECTIOUSDISEASES - touchIMMUNOLOGY - touchRESPIRATORY - touchHAEMATOLOGY - touchDERMATOLOGY This information is intended for use by licensed Healthcare Professionals (HCPs). It should not be considered medical advice, diagnosis, or treatment recommendations.
Episodes
Friday Sep 17, 2021
Friday Sep 17, 2021
touchEXPERT OPINIONS for touchONCOLOGY
Listen to leading experts discuss evolving treatment options for patients with advanced basal cell carcinoma, and how novel immunotherapeutic approaches within the emerging clinical study landscape may improve patient care.
The experts
- Prof. Axel Hauschild, University Hospital Schleswig-Holstein, Kiel, Germany
- Dr Emily Ruiz, Brigham and Women’s Hospital, Boston, MA, USA
- Prof. Ketty Peris, Catholic University of Rome, Rome, Italy
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Regeneron Pharmaceuticals, Inc. This activity is jointly provided by USF Health and touchIME.
Wednesday Sep 15, 2021
Wednesday Sep 15, 2021
touchMDT for touchONCOLOGY
Listen to a medical oncologist and an oncology nurse practitioner discuss how to involve the patient in treatment decisions and the role of the multidisciplinary team in keeping abreast of the latest data.
The multidisciplinary team
- Medical oncologist: Dr David Planchard, France
- Oncology nurse practitioner: Ms Beth Sandy, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.org/evolving-role-mdt-early-nsclc/
Wednesday Sep 15, 2021
Wednesday Sep 15, 2021
touchMDT for touchONCOLOGY
Listen to a medical oncologist and a pathologist discuss the benefits of biomarker testing in early and locally advanced NSCLC.
The multidisciplinary team
- Medical oncologist: Dr David Planchard, France
- Molecular pathologist: Prof. Albrecht Stenzinger, Germany
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.org/evolving-role-mdt-early-nsclc/
Wednesday Sep 15, 2021
Wednesday Sep 15, 2021
touchMDT for touchONCOLOGY
Listen to a medical oncologist, a pulmonologist and a thoracic surgeon as they assess the suitability of a patient with NSCLC for surgery and expanding treatment options.
The multidisciplinary team
- Medical oncologist: Dr David Planchard, France
- Pulmonologist: Prof. Johan Vansteenkiste, Belgium
- Thoracic surgeon: Dr Masahiro Tsuboi, Japan
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.org/evolving-role-mdt-early-nsclc/
Thursday Jul 29, 2021
Thursday Jul 29, 2021
touchPANEL DISCUSSION for touchCARDIO
Listen to leading experts discuss how patients can be best supported following a diagnosis of HFrEF, how to implement evidence-based therapies into practice including the potential impact of emerging therapies on treatment selection, and the role of biomarkers in diagnosing, monitoring and determining treatment course for individuals with HFrEF.
The experts
- Prof. Piotr Ponikowski, Wrocław Medical University, Wrocław, Poland
- Prof. Adriaan A Voors, University Medical Centre Groningen, Groningen, The Netherlands
- Dr Stephen Greene, Duke University, Durham, NC, USA
This touchPODCAST is for HCPs only.
Funding for this touchPODCAST is from an unrestricted independent educational grant from Bayer, Merck & Co and AstraZeneca. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchcardioime.org/aiming-for-improved-outcomes-in-hfref
Tuesday Jul 20, 2021
Tuesday Jul 20, 2021
touchCONGRESS for touchONCOLOGY
Listen to Prof. Uwe Platzbecker (Germany) cover key data presented at EHA2021 Virtual on new and emerging treatments for the improvement of outcomes in higher-risk MDS and newly diagnosed AML, including expert insights and interpretation from Prof. Valeria Santini (Italy) and Prof. Andrew Wei (Australia).
This touchPODCAST is for HCPs only.
Funding for this touchPODCAST is from an unrestricted independent educational grant from Novartis. The content was led by touchIME.
For further information visit our website: https://touchoncologyime.org/MDS-AML-EHA2021-touchcongress/
Tuesday Jul 20, 2021
Tuesday Jul 20, 2021
touchMDT for touchCARDIO
Listen to key experts from a multidisciplinary team consider the latest data for novel lipid-lowering therapies and what they may mean for their patients with dyslipidaemia
The multidisciplinary team
- Primary care physician: Dr Yassir Javaid, UK
- Cardiologist: Dr Constantine Kosmas, USA
- Endocrinologist: Professor Lawrence Leiter, Canada
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Novartis Pharma AG, Basel, Switzerland. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchcardioime.org/novel-lipid-lowering-therapies-for-reducing-ASCVD-risk/
Tuesday Jul 20, 2021
Tuesday Jul 20, 2021
touchMDT for touchENDOCRINOLOGY
Listen to key experts from a multidisciplinary team consider the unmet needs in patients at high risk of ASCVD and how novel lipid-lowering therapies may help
The multidisciplinary team
- Endocrinologist: Professor Lawrence Leiter, Canada
- Cardiologist: Dr Constantine Kosmas, USA
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Novartis Pharma AG, Basel, Switzerland. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
https://touchendocrinologyime.org/novel-lipid-lowering-therapies-for-reducing-ascvd-risk/
Tuesday Jul 20, 2021
Tuesday Jul 20, 2021
touchMDT for touchENDOCRINOLOGY
Listen to key experts from a multidisciplinary team discuss the risk factors and lipoproteins associated with ASCVD and guideline recommendations for the management of patients with dyslipidemia
The multidisciplinary team
- Cardiologist: Dr Constantine Kosmas, USA
- Primary care physician: Dr Yassir Javaid, UK
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Novartis Pharma AG, Basel, Switzerland. This medical education is provided by touchIME.
Tuesday Jul 20, 2021
Tuesday Jul 20, 2021
touchMDT for touchCARDIO
Listen to key experts from a multidisciplinary team consider the latest data for novel lipid-lowering therapies and what they may mean for their patients with dyslipidaemia
The multidisciplinary team
- Primary care physician: Dr Yassir Javaid, UK
- Cardiologist: Dr Constantine Kosmas, USA
- Endocrinologist: Professor Lawrence Leiter, Canada
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Novartis Pharma AG, Basel, Switzerland. This medical education is provided by touchIME.
For further information visit our website: https://touchcardioime.org/novel-lipid-lowering-therapies-for-reducing-ascvd-risk//